O'Kane D - Search Results

1

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Am J Gastroenterol. 2002 Jul;97(7):1763-8. doi: 10.1111/j.1572-0241.2002.05838.x. Am J Gastroenterol. 2002. PMID: 12135032

2

CYP2C19 variation and citalopram response.

Mrazek DA, Biernacka JM, O'Kane DJ, Black JL, Cunningham JM, Drews MS, Snyder KA, Stevens SR, Rush AJ, Weinshilboum RM. Mrazek DA, et al. Pharmacogenet Genomics. 2011 Jan;21(1):1-9. doi: 10.1097/fpc.0b013e328340bc5a. Pharmacogenet Genomics. 2011. PMID: 21192344 Free PMC article. Clinical Trial.

3

Gene expression microarrays.

Kolbert CP, Taylor WR, Krajnik KL, O'Kane DJ. Kolbert CP, et al. Methods Mol Med. 2003;85:239-55. doi: 10.1385/1-59259-380-1:239. Methods Mol Med. 2003. PMID: 12710212 Review. No abstract available.

4

SLC6A4 variation and citalopram response.

Mrazek DA, Rush AJ, Biernacka JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL 3rd, Weinshilboum RM. Mrazek DA, et al. Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341-51. doi: 10.1002/ajmg.b.30816. Am J Med Genet B Neuropsychiatr Genet. 2009. PMID: 18618621 Free PMC article.

5

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.

Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA. Moyer TP, et al. Mayo Clin Proc. 2009 Dec;84(12):1079-94. doi: 10.4065/mcp.2009.0278. Mayo Clin Proc. 2009. PMID: 19955245 Free PMC article. Review.

6

Pharmacogenomics and reducing the frequency of adverse drug events.

O'Kane DJ, Weinshilboum RM, Moyer TP. O'Kane DJ, et al. Pharmacogenomics. 2003 Jan;4(1):1-4. doi: 10.1517/phgs.4.1.1.22588. Pharmacogenomics. 2003. PMID: 12517278 No abstract available.

7

Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism.

Baudhuin LM, Highsmith WE, Skierka J, Holtegaard L, Moore BE, O'Kane DJ. Baudhuin LM, et al. Clin Biochem. 2007 Jun;40(9-10):710-7. doi: 10.1016/j.clinbiochem.2007.03.007. Epub 2007 Mar 23. Clin Biochem. 2007. PMID: 17459361

8

Pharmacogenomics of tamoxifen and irinotecan therapies.

Algeciras-Schimnich A, O'Kane DJ, Snozek CL. Algeciras-Schimnich A, et al. Clin Lab Med. 2008 Dec;28(4):553-67. doi: 10.1016/j.cll.2008.05.004. Clin Lab Med. 2008. PMID: 19059062 Review.

9

The impact of CYP allelic variation on antidepressant metabolism: a review.

Black JL 3rd, O'Kane DJ, Mrazek DA. Black JL 3rd, et al. Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):21-31. doi: 10.1517/17425255.3.1.21. Expert Opin Drug Metab Toxicol. 2007. PMID: 17269892 Review.

10

Cytochrome P450 2D6 genotype variation and venlafaxine dosage.

McAlpine DE, O'Kane DJ, Black JL, Mrazek DA. McAlpine DE, et al. Mayo Clin Proc. 2007 Sep;82(9):1065-8. doi: 10.4065/82.9.1065. Mayo Clin Proc. 2007. PMID: 17803873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters